Search for: "Anda Pharmaceuticals, Inc"
Results 341 - 360
of 607
Sort by Relevance
|
Sort by Date
29 Aug 2011, 12:30 pm
09-1039), and Actavis, Inc. v. [read post]
29 Aug 2011, 5:53 am
After the Federal Circuit's decision in Thereasense, Inc. v. [read post]
28 Aug 2011, 9:57 pm
Apotex Inc. et al. 4:11-cv-00600; filed August 25, 2011 in the Northern District of Texas • Plaintiffs: Alcon Pharmaceuticals, Ltd.; Alcon Research, Ltd. [read post]
27 Aug 2011, 7:55 pm
Creating a bioequivalent of Miacalin® would allow approval of the new pharmaceutical liquid dosage form as an ANDA under 21 U.S.C. [read post]
24 Aug 2011, 4:17 am
., Inc., No. 10 C 112 (N.D. [read post]
17 Aug 2011, 3:00 pm
Endo Pharmaceuticals, Inc., C.A. [read post]
11 Aug 2011, 5:25 pm
As we previously reported, the statutory counterclaims provisions were recently asserted in the context of a 505(b)(2) application for Intelliject, Inc. [read post]
10 Aug 2011, 8:59 am
Mylan Pharmaceuticals Inc., C.A. [read post]
8 Aug 2011, 5:18 pm
Karst – FDA’s recent approval of ANDA No. 090358 for an AB-rated generic version of IMITREX STATdose (sumatriptan succinate) Injection, approved under NDA No. 020080, puts some meat on the bones of the Agency’s July 2009 consolidated response to two citizen petitions (here and here) submitted by King Pharmaceuticals, Inc. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
31 Jul 2011, 9:44 pm
Hetero Drugs Ltd. et al. 1:11-cv-05135; filed July 26, 2011 in the Southern District of New York • Plaintiffs: Pfizer Inc.; Pfizer Ltd.; Pfizer Ireland Pharmaceuticals • Defendants: Hetero Drugs Ltd.; Hetero USA Inc.; Invagen Pharmaceuticals Inc.; Hetero Labs Ltd., Unit V Infringement of U.S. [read post]
28 Jul 2011, 8:09 pm
., Inc. v. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
21 Jul 2011, 10:48 pm
See Schwarz Pharma, Inc. v. [read post]
18 Jul 2011, 5:16 pm
Circuit’s March 2, 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
10 Jul 2011, 9:20 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
7 Jul 2011, 3:38 pm
District Court for the District of New Jersey issued a 19-page decision in Nostrum Pharmaceuticals, LLC. v. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
1 Jul 2011, 8:06 am
In OSI Pharmaceuticals, Inc. v. [read post]
30 Jun 2011, 2:13 pm
Patent No. 7,915,307...This action relates to an Abbreviated New Drug Application ("ANDA") filed by Mylan Pharmaceuticals, Inc. with the U.S. [read post]
